125 related articles for article (PubMed ID: 11514164)
1. Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists.
Witherington J; Bordas V; Cooper DG; Forbes IT; Gribble AD; Ife RJ; Berkhout T; Gohil J; Groot PH
Bioorg Med Chem Lett; 2001 Aug; 11(16):2177-80. PubMed ID: 11514164
[TBL] [Abstract][Full Text] [Related]
2. CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound.
Forbes IT; Cooper DG; Dodds EK; Hickey DM; Ife RJ; Meeson M; Stockley M; Berkhout TA; Gohil J; Groot PH; Moores K
Bioorg Med Chem Lett; 2000 Aug; 10(16):1803-6. PubMed ID: 10969972
[TBL] [Abstract][Full Text] [Related]
3. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
[TBL] [Abstract][Full Text] [Related]
4. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
Rowley M; Hallett DJ; Goodacre S; Moyes C; Crawforth J; Sparey TJ; Patel S; Marwood R; Patel S; Thomas S; Hitzel L; O'Connor D; Szeto N; Castro JL; Hutson PH; MacLeod AM
J Med Chem; 2001 May; 44(10):1603-14. PubMed ID: 11334570
[TBL] [Abstract][Full Text] [Related]
5. Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives.
Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Sudo M; Tsutsumi T; Endo N; Muroga Y; Hada T; Tanaka H; Morita T; Greene J; Barnum D; Saunders J; Kato Y; Myers PL; Tarby CM
Bioorg Med Chem Lett; 2004 Nov; 14(21):5413-6. PubMed ID: 15454236
[TBL] [Abstract][Full Text] [Related]
6. Probing the structural and topological requirements for CCR2 antagonism: holographic QSAR for indolopiperidine derivatives.
Srikanth K; Nair PC; Sobhia ME
Bioorg Med Chem Lett; 2008 Feb; 18(4):1450-6. PubMed ID: 18226895
[TBL] [Abstract][Full Text] [Related]
7. Selective, centrally acting serotonin 5-HT2 antagonists. 1. 2- and 6-substituted 1-phenyl-3-(4-piperidinyl)-1H-indoles.
Perregaard J; Andersen K; Hyttel J; Sánchez C
J Med Chem; 1992 Dec; 35(26):4813-22. PubMed ID: 1336053
[TBL] [Abstract][Full Text] [Related]
8. N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptor.
Kettle JG; Faull AW; Barker AJ; Davies DH; Stone MA
Bioorg Med Chem Lett; 2004 Jan; 14(2):405-8. PubMed ID: 14698169
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
10. Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR.
Grundt P; Husband SL; Luedtke RR; Taylor M; Newman AH
Bioorg Med Chem Lett; 2007 Feb; 17(3):745-9. PubMed ID: 17095222
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.
Xia M; Hou C; Pollack S; Brackley J; DeMong D; Pan M; Singer M; Matheis M; Olini G; Cavender D; Wachter M
Bioorg Med Chem Lett; 2007 Nov; 17(21):5964-8. PubMed ID: 17869105
[TBL] [Abstract][Full Text] [Related]
13. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
[TBL] [Abstract][Full Text] [Related]
15. Dopamine/serotonin receptor ligands. Part IV [1]: synthesis and pharmacology of novel 3-benzazecines and 3-benzazonines as potential 5-HT2A and dopamine receptor ligands.
El-Subbagh H; Wittig T; Decker M; Elz S; Nieger M; Lehmann J
Arch Pharm (Weinheim); 2002 Nov; 335(9):443-8. PubMed ID: 12447918
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological activity of metabolites of the 5-HT(4) receptor antagonist SB-207266.
Fedouloff M; Hossner F; Voyle M; Ranson J; Powles J; Riley G; Sanger G
Bioorg Med Chem; 2001 Aug; 9(8):2119-28. PubMed ID: 11504648
[TBL] [Abstract][Full Text] [Related]
17. 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.
Bernotas RC; Antane S; Shenoy R; Le VD; Chen P; Harrison BL; Robichaud AJ; Zhang GM; Smith D; Schechter LE
Bioorg Med Chem Lett; 2010 Mar; 20(5):1657-60. PubMed ID: 20138763
[TBL] [Abstract][Full Text] [Related]
18. 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.
Watson PS; Jiang B; Harrison K; Asakawa N; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Ko SS
Bioorg Med Chem Lett; 2006 Nov; 16(21):5695-9. PubMed ID: 16931001
[TBL] [Abstract][Full Text] [Related]
19. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.
Crawforth J; Goodacre S; Maxey R; Bourrain S; Patel S; Marwood R; O'Connor D; Herbert R; Hutson P; Rowley M
Bioorg Med Chem Lett; 2000 Dec; 10(24):2701-3. PubMed ID: 11133072
[TBL] [Abstract][Full Text] [Related]
20. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
Holenz J; Mercè R; Díaz JL; Guitart X; Codony X; Dordal A; Romero G; Torrens A; Mas J; Andaluz B; Hernández S; Monroy X; Sánchez E; Hernández E; Pérez R; Cubí R; Sanfeliu O; Buschmann H
J Med Chem; 2005 Mar; 48(6):1781-95. PubMed ID: 15771424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]